financetom
Business
financetom
/
Business
/
Startup Rivos raises $250 million to develop RISC-V AI chips
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Startup Rivos raises $250 million to develop RISC-V AI chips
Apr 16, 2024 6:24 AM

April 16 (Reuters) - Chip startup Rivos said on Tuesday

it raised $250 million in a funding round that will enable it to

manufacture its first server chip geared for artificial

intelligence.

Nvidia's ( NVDA ) combination of chips and CUDA software

dominates the market for AI-related computing, and Nvidia ( NVDA )

gobbled up more than 80% market share of AI chips in 2023. But a

host of startups and chip giants have started to launch

competing products, such as Intel's ( INTC ) Gaudi 3 and Meta's inference

chip - both unveiled last week.

Rivos is tight-lipped about the specifics of the product,

but has disclosed that its plans include designing chips based

on the RISC-V architecture, which is an open source alternative

to the architectures made by Arm , Intel ( INTC )

and Advanced Micro Devices ( AMD ). Instruction set

architectures such as RISC-V are the building blocks of

semiconductor designs, and using the open source alternative

means Rivos does not have to pay a license fee to Arm.

"RISC-V doesn't have a (large) software ecosystem, so I

decided to form a company and then build software-defined

hardware - just like what CUDA did with Nvidia ( NVDA )," said Lip-Bu

Tan, founding managing partner at Walden Catalyst, one of Rivos'

investors.

Santa Clara, California-based Rivos is in the process of

designing a server chip that combines a central processing unit

and AI accelerator component that will be optimized for large

language models and data analytics. The company began with the

software necessary to compile computer code to allow the chip to

run a program and designed the processor around the software.

"Usually the chip companies do it the other way: build the

silicon, and then build the software on top," CEO Puneet Kumar

told Reuters in an interview. "We decided, as a company that we

should first look at software."

Matrix Capital Management was the largest investor in the

funding round that also included investments from Intel ( INTC ),

MediaTek ( MDTTF ) and Dell Technologies ( DELL ).

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
XPEL Acquires Assets of Chinese Distributor
XPEL Acquires Assets of Chinese Distributor
Sep 11, 2025
09:09 AM EDT, 09/11/2025 (MT Newswires) -- XPEL ( XPEL ) said Thursday it has acquired the assets of its exclusive distributor in China aftermarket. Financial terms of the transaction were not disclosed. The transaction structure will result in XPEL ( XPEL ) owning a 76% interest in the Chinese entity conducting business in China. The company said the purchase...
Sector Update: Consumer Stocks Advance Premarket Thursday
Sector Update: Consumer Stocks Advance Premarket Thursday
Sep 11, 2025
09:14 AM EDT, 09/11/2025 (MT Newswires) -- Consumer stocks were advancing premarket Thursday, with the Consumer Discretionary Select Sector SPDR Fund ( XLY ) up 0.3% and the Consumer Staples Select Sector SPDR Fund ( XLP ) 0.1% higher. Alibaba Group ( BABA ) shares were up 3.1% after the company said it priced a $3.2 billion offering of zero...
Protagonist Says Johnson & Johnson Submits Application to EMA for Plaque Psoriasis Treatment
Protagonist Says Johnson & Johnson Submits Application to EMA for Plaque Psoriasis Treatment
Sep 11, 2025
09:12 AM EDT, 09/11/2025 (MT Newswires) -- Protagonist Therapeutics ( PTGX ) said Thursday that its partner, Johnson & Johnson ( JNJ ) , has submitted an application to the European Medicines Agency seeking approval of icotrokinra to treat moderate-to-severe plaque psoriasis in adults and adolescents above 12 years of age. The investigational oral tablet selectively blocks the IL-23 receptor,...
T. Rowe Price Group August Assets Under Management Rise Month Over Month
T. Rowe Price Group August Assets Under Management Rise Month Over Month
Sep 11, 2025
09:13 AM EDT, 09/11/2025 (MT Newswires) -- T. Rowe Price ( TROW ) reported preliminary assets under management Thursday of $1.729 trillion as of Aug 31, up from $1.703 trillion in the previous month. The company said its equity assets rose to $867 billion at the end of August from $859 billion as of July 31, and multi-assets increased to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved